Sequential HAIC-TACE combined with targeted and immunotherapy in hepatocellular carcinoma: a quality improvement study
{{output}}
Background: Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality. Emerging evidence suggests that quadruple therapy-combining hepatic artery infusion chemotherapy (HAIC), transarterial chemoembolization (TAC... ...
